News
We provide the latest news from the world of economics and finance
(RTTNews) - Soleno Therapeutics, Inc. (SLNO), a developer of novel therapeutics for the treatment of rare diseases, said on Thursday that it has appointed Jennifer Fulk as Chief Financial Officer.
She will succeed James Mackaness, who will retire from the company by the end of the first quarter.
Fulk served as Chief Operating Officer and Chief Financial Officer of 120Water, Inc. from September 2024 through October 2025.
Previously, she served as Chief Financial Officer of Talkspace, Inc., a virtual behavioral healthcare company, from July 2021 to May 2024.
Fulk also spent over 15 years at Eli Lilly and Company in various finance executive roles, including Chief Financial Officer of U.S. Bio-Medicines.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2026 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
E-mail: 24_support@j2t.com
